XML 23 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows from Operating Activities:    
Net income (loss) $ 52,214 $ 1,006
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation expense, intangible asset and other amortization 11,214 10,878
Stock-based compensation 7,995 3,621
Amortization of deferred commissions 569 517
Payments of deferred commissions (1,253) (518)
Equity in earnings of equity method investments (1,028) (657)
(Gain) loss on extinguishment of debt 0 (705)
Sales (purchases) of investments, net (25) 2,153
Deferred taxes, net 377 7,175
Changes in operating assets and liabilities:    
Accounts receivable, net and other assets (27,102) 6,377
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities (36,543) (64,917)
Operating activities of consolidated investment products ("CIP"):    
Net cash provided by (used in) operating activities 150,151 (252,320)
Cash Flows from Investing Activities:    
Capital expenditures and other asset purchases (2,560) (358)
Net cash provided by (used in) investing activities (2,608) 9,366
Cash Flows from Financing Activities:    
Payment of long term debt (5,913) (26,547)
Common stock dividends paid (7,117) (5,832)
Preferred stock dividends paid 0 (2,084)
Repurchases of common shares (4,999) (10,000)
Stock options exercised 66 101
Taxes paid related to net share settlement of restricted stock units (15,163) (3,551)
Net subscriptions received from (redemptions/distributions paid to) noncontrolling interests (19,004) 728
Net cash provided by (used in) financing activities (87,673) 314,641
Net increase (decrease) in cash, cash equivalents and restricted cash 59,870 71,687
Cash, cash equivalents and restricted cash, beginning of period 339,849 321,939
Cash, cash equivalents and restricted cash, end of period 399,719 393,626
Non-Cash Investing Activities:    
Change in accrual for capital expenditures 45 (20)
Contingent consideration 137,664 0
Non-Cash Financing Activities:    
Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net 0 17,137
Common stock dividends payable 6,219 5,175
Conversion of preferred stock to common stock 0 115,000
Reconciliation of cash, cash equivalents and restricted cash    
Cash, cash equivalents and restricted cash at end of period 339,849 393,626
Consolidated entity excluding consolidated investment products    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Realized and unrealized (gains) losses on investments, net (889) 7,544
Consolidated Investment Products    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Realized and unrealized (gains) losses on investments, net 2,066 6,581
Operating activities of consolidated investment products ("CIP"):    
Purchases of investments by CIP (250,865) (509,337)
Sales of investments by CIP 377,388 273,962
Net proceeds (purchases) of short term investments by CIP 16,693 (396)
(Purchases) sales of securities sold short by CIP, net 23 181
Change in other assets of CIP 287 (17)
Change in liabilities of CIP (970) 932
Amortization of discount on notes payable of CIP 0 3,300
Cash Flows from Investing Activities:    
Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net (48) 9,724
Cash Flows from Financing Activities:    
Payments on borrowings by CIP (35,543) (40,690)
Borrowings by CIP $ 0 $ 402,516